Skip to main content
FinSpry Logo
FinSpry
TARA logo
TARA
(NASDAQ)
Protara Therapeutics, Inc.
$5.11-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Protara Therapeutics (TARA) Stock Price & Financial Analysis

Protara Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.86 - $5.13
52-Week High$7.82
52-Week Low$2.77
Open$4.90
Volume511.47K
Average Volume (3M)511.47K
Market Cap218.89M
Shares Outstanding42.84M
Price to Book (P/B)1.10
EV/EBITDA-2.67
50-Day MA$6.05
200-Day MA$4.80
52-Week Change25.69%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Protara Therapeutics

What is the current stock price for TARA?

As of the latest trading session, TARA stock trades at $5.11. The 52-week range is $2.77–$7.82, with a day range of $4.86–$5.13.

What is the P/E ratio for TARA?

The P/E ratio (Price-to-Earnings) for TARA is shown in the Key Statistics section. This valuation metric helps compare Protara Therapeutics, Inc. to industry peers.

Does TARA pay dividends?

Protara Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for TARA?

Based on 3 analysts, the consensus for TARA is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of TARA?

Protara Therapeutics's market capitalization is $218.9M, classifying it as a micro-cap company. Protara Therapeutics operates in the Healthcare sector within the Biotechnology industry.